Smooth muscle antibodies of low titre are found by immunofluorescence (IFL) in 12 % of normal subjects (Holborow et al, 1973; Sutton et al, 1974) and as a temporary phenomenon in up to 80 % of patients with virus infections, especially infectious hepatitis (Farrow et al, 1970; Ajdukiewicz et al, 1972; Walker et al, 1970) , infectious mononucleosis (Holborow et al, 1973; Sutton et al, 1974) and warts (McMillan and Haire, 1975) . They are also seen in malignancies not necessarily involving the liver (Whitehouse and Holborow, 1971; Wasserman et al, 1975) . These antibodies are unrelated to age and sex and their frequency is not increased in families predisposed to autoimmunity (Galbraith et al, 1974) . It is thought that they are produced in response to tissue injury following the release of proteins from the cells (Holborow, 1972; Becker and Nachman, 1973; Behnke, 1974) . SMA were first described in patients with chronic active hepatitis (Johnson et al, 1965; Doniach et al, 1966; Whittingham et al, 1966a) , and it is true that the highest titres are seen in this disease where they may persist for years. In addition to their reaction with smooth muscle fibres in all tissues from various species, it was soon noted that some sera also stained renal glomeruli (Whittingham et al, 1966b) . Fluorescence of intracellular fibrils in the peripheral cyto-plasm of liver cells includes the 'polygonal' and socalled 'bile-canalicular' patterns (Johnson et al, 1966; Farrow et al, 1971) . Similar staining occurs in thyroid (Sutton et al, 1974; Biberfeld et al, 1974; Lidman et al, 1974) . However, peripheral IFL is also seen without associated smooth muscle fibre staining .
The multiple staining patterns observed with sera from patients with chronic liver diseases and, more significantly, with monoclonal immunoglobulins having SMA reactivity (Wager et al, 1971; Roux et al, 1974) .
EXTRACTION OF CONTRACTILE PROTEINS
Whole smooth muscle homogenates from human uterus (Anderson, 1974) and pig stomach (Fagraeus et al, 1973) have been shown to absorb SMA sera. Therefore we attempted to identify the antigen by using subfractions. Actin was prepared by the method described by Adelstein et al (1963) , actomyosin according to Becker (1972) The staining of the actual smooth muscle fibres did not differ consistently in SMA-V, -G or -T sera although individual appearances were not always identical. The three patterns could be distinguished clearly from each other only with fairly high titre sera, and on increasing dilutions the vascular SMA could be seen beyond the point where small fibrils in glomeruli and epithelial structures became invisible. The same three patterns were obtained with human, rat, and mouse kidney.
REACTIONS WITH SKELETAL MUSCLE
In view of the localization of actin in the I-bands of skeletal muscle, SMA-T and -G sera should show striational IFL if this is the main antigen. On cryostat sections this could be seen only with hightitre sera, and the IFL was always weaker than on smooth muscle fibres.
THYMUS, LYMPH-NODE, AND SPLEEN IFL
Eighty-two sera were tested on mouse, calf or human thymus. No species differences could be detected so most of the detailed work was done on mouse thymus. Twenty-nine sera stained both medulla and cortex (fig 4) , 18 reacted with medulla, and 35 were negative. The staining consisted of a cytoplasmic rim in the periphery of thymocytes in acetone-fixed sections. Viable thymocytes showed no staining with any SMA sera. In addition, 17 sera gave a streaky IFL in the cortical area ( fig 5) . Correlation of SMA patterns with thymic reactivity is shown in table II. Twenty-six of the 29 sera giving positive IFL in both medulla and cortex belonged to the SMA-T group, while none of the SMA-V showed any reactivity with the thymus. Of 17 sera showing 'streaks' in the cortex, 13 were SMA-T and four were SMA-G; none of the SMA-V sera showed this reactivity.
Since it was suggested that SMA sera could stain T-cells selectively (Fagraeus et al, 1973 ) a comparison was made with an anti-mouse brain associated theta (BA-0) (Gyongyossy and Playfair, 1973) using the double IFL technique with rhodamine and FITC. SMA sera reacting only with thymic medulla, or those which stained both medulla and cortex, gave the same pattern as anti-theta on lymph node and spleen, ie, they stained only the T-lymphocytes. In the thymus, anti-theta was always brighter on cortical lymphocytes. 'Streaks' were never seen with anti-theta (table III) .
CLINICAL ASSOCIATIONS OF SMA FLUORESCENCE
Of 312 sera in which the SMA pattern was determined, 139 came from patients with liver disorders and 173 mainly from patients with viral infections, autoimmune disorders, and a variety of malignancies (table IV) . The overall distribution of patterns showed that half the sera were SMA-V, 28% were SMA-T, and 22% SMA-G. High titres (80-640) of SMA-T and -G were more frequent in chronic liver diseases while SMA-V showed a higher prevalence in the group of miscellaneous conditions, and at low titres also in liver cases.
Assessment of the distribution of SMA variants in liver disorders was confined to high titres since these are more significant in relation to 'autoimmune' liver diseases (table V) . Sera from patients with chronic active hepatitis (CAH) had SMA-T and -G about equally and SMA-V less often (3/42). 'Autoimmune' CAH cases were subdivided into those who also had high ANA titres (lupoid variant) and a much less frequent disease where persistent SMA is the only marker (Doniach and Bottazzo, 1976) . In viral hepatitis SMA titres rarely go above 80 and SMA-T and -V tended to be more frequent. Cirrhosis represents a mixed group, and no correlations could be made regarding the SMA patterns. Thyroid peripheral IFL with negative hepatocyte staining was seen in seven instances, three SMA-T and four SMA-V. Here again, the appearances were not totally uniform, some sera showing a thick line and others a very slender one at the periphery of the thyroid epithelial cells. Both liver and thyroid showed peripheral IFL with 11 sera, all corresponding to SMA-T. The presence or absence of peripheral IFL in these two organs did not correlate with the SMA titre. In some sera, titration on kidney, thyroid, and liver reached the same endpoint, while in others the peripheral IFL in the latter two organs disappeared more quickly. As seen in table VI, these correlations were not specifically related to liver diseases.
ABSORPTION STUDIES
Forty-three sera with SMA reactivity in titres between 40 and 640 were absorbed with purified actin. Twenty-four were SMA-T, 18 SMA-G, and one SMA-V. Only two sera could not be absorbed with actin-the SMA-V serum and an unusual SMA-T serum which also stained intercalated discs in heart muscle and was derived from a child with a retroperitoneal tumour. Forty-one sera lost all their IFL, including the staining on liver and thyroid.
Discussion
The present attempt to classify smooth muscle antibodies occurring in human sera was morphological. It has been obvious for some years that a number of IFL patterns were observed on different tissues. At first it was considered that individual sera contained a mixture of antibodies to related tissue antigens but when monoclonal proteins with SMA reactivity showed different IFL patterns it encouraged the idea that these could be due to a single SMA-related antigen distributed in many cell types. Gabbiani et al (1973) were the first to suggest that sera from chronic active hepatitis cases contained anti-actin antibodies, and this was confirmed by Fagraeus and her co-workers and now also by our results. Actin of almost identical composition is widely distributed in animal tissues (Pollard and Weihing, 1974) , especially in smooth and striated muscle, and in intracellular contractile fibrils (Lazarides and Weber, 1974; Fagraeus et al, 1975; Norberg et al, 1975) of liver, thyroid, and kidney, including the glomerulus. Trenchev et al (1974) raised anti-actin antibodies in rabbits and obtained glomerular staining and a pattern on other organs resembling SMA-T.
Strong human anti-actin antibodies stain kidney with the SMA-T pattern and also show a pericellular IFL on liver and thyroid but some weak sera may give the SMA-V appearance yet be absorbed by actin. Nevertheless there are high-titre sera of SMA-G pattern that were completely absorbed with actin, suggesting that some patients may make antibodies to different antigenic sites on the actin molecule, some of which may not be exposed in intracellular fibrils. The inability to stain skeletal muscle I bands by weaker sera is further evidence that the actin antigenic sites may be inaccessible owing to the surrounding myosin filaments, depending on the degree of contraction during fixation. Some hightitre SMA sera cannot be absorbed by actin and we have evidence that there are at least three other antigens involved. The high-titre SMA-V sera are against antigens peculiar to smooth muscle and one of these is probably an anti-smooth muscle myosin (Fairfax et al, unpublished) , while others may be against proteins surrounding the contractile fibrils. The SMA-T serum which could not be absorbed by actin showed a very unusual pattern. The antigen has not yet been identified and appears related to cell junctions in smooth and cardiac muscle, and in Purkinje fibres.
The thymus results corresponded, to a certain degree, with those reported by Fagraeus et al (1973) . Three of our anti-actin sera showed staining of the cortex and medulla but no 'streaks', while one serum which could not be absorbed showed streaks, suggesting that this pattern corresponds to a different antigen.
In view of the high SMA titres seen in some cases of CAH an attempt was made to correlate subgroups of this syndrome with the SMA patterns (table V).
In 'lupoid' hepatitis ANA is the chief marker and about half the cases also showed SMA which could be SMA-T or SMA-G and more rarely SMA-V. In addition, there is a small group of patients showing persistent SMA in the absence of ANA, who could represent a different disease (Dawkins and Joske, 1973) . It is as yet unexplained why antibodies to actin should be a particular feature of the autoimmune forms of CAH, while antibodies to other smooth muscle proteins were found mostly in patients with disorders not involving the liver. 
